Pregnancy and Developmental Outcomes After Transfer of Reportedly Aneuploid or Mosaic Embryos

Part of paid clinical trials in Sunnyvale, California.

Sponsor
Stanford University
Study ID
NCT04109846
Status
Recruiting
Apply to this trial

Conditions

  • Aneuploidy
  • Mosaicism
  • Pregnancy Outcome

Eligibility Criteria

Sex
FEMALE
Age
18 Years - 55 Years
Healthy Volunteers
Accepted

Interventions

  • Non-euploid embryo transfer — OTHER
    Other than choice of embryo for transfer, all other medical interventions will be standard of care protocols
  • Euploid Transfer — OTHER
    Standard of Care Protocol

Study Details

To determine how often embryos reported to be abnormal by preimplantation genetic testing result in liveborn infants. To evaluate whether the pregnancies that result from these embryos are higher risk for complications and whether the resulting babies have higher risk for health or developmental issues in the first five years after birth.

Key Dates

Start date
Apr 11, 2019
Status verified
Apr 2026
Primary completion
Apr 30, 2035
Completion
Apr 1, 2039

Study Design

Enrollment
300 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Non-euploid Transfer
    Patients desiring pregnancy who have no acceptable euploid embryos available for transfer who chose to undergo embryo transfer of a non-euploid embryo (either aneuploid or mosaic).
  • Active Comparator: Euploid Transfer
    Patients desiring pregnancy who are undergoing euploid embryo transfer

Primary Outcome Measure

Pregnancy Rate [ Time Frame: 3 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Stanford Fertility and Reproductive Medicine CenterSunnyvaleCalifornia94087
Ronit Mazzoni, MS
[email protected]
408-688-9749
Ruth Lathi, MD
[email protected]
650-498-7911

Find similar trials in Sunnyvale, CA

By research site
Stanford Fertility and Reproductive Medicine Center· Sunnyvale, CA

Related Studies